Axomadol
Axomadol is a synthetic opioid analgesic that is used for the treatment of moderate to severe pain. It is structurally related to tramadol and functions as a centrally acting analgesic. Axomadol is known for its dual mechanism of action, which includes both opioid receptor agonism and inhibition of serotonin and norepinephrine reuptake.
Pharmacology
Axomadol exerts its analgesic effects primarily through its action on the mu-opioid receptor (MOR). By binding to these receptors, it mimics the effects of endogenous endorphins, leading to pain relief. Additionally, axomadol inhibits the reuptake of serotonin and norepinephrine, which enhances its analgesic properties and contributes to its effectiveness in treating neuropathic pain.
Mechanism of Action
The dual mechanism of action of axomadol involves:
- Agonism at the mu-opioid receptor, which provides potent analgesia.
- Inhibition of the reuptake of serotonin and norepinephrine, which modulates pain perception and provides additional analgesic effects.
Clinical Use
Axomadol is prescribed for the management of moderate to severe pain, including both acute and chronic pain conditions. It is particularly useful in cases where other analgesics, such as nonsteroidal anti-inflammatory drugs (NSAIDs), are ineffective or contraindicated.
Side Effects
Common side effects of axomadol include:
Serious side effects may include:
Contraindications
Axomadol should not be used in patients with:
- Severe respiratory depression
- Acute or severe bronchial asthma
- Known hypersensitivity to axomadol or any of its components
Interactions
Axomadol may interact with other medications, including:
- Other opioids
- Monoamine oxidase inhibitors (MAOIs)
- Selective serotonin reuptake inhibitors (SSRIs)
- Serotonin-norepinephrine reuptake inhibitors (SNRIs)
Regulation
As an opioid analgesic, axomadol is subject to regulation under various national and international drug control laws. It is classified as a controlled substance in many countries due to its potential for abuse and dependence.
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD